CLINICAL STUDIES

If you are interested in being an investigator for Endo clinical trials, please click here.

If you are interested in participating in the CARCINOID SYNDROME clinical trial, please see below.


CARCINOID SYNDROME

If you have Carcinoid Syndrome, are of ages 18 years to 80 years old and are interested in being considered to participate in this clinical trial currently being conducted, please click here.

If you are a physician interested in being an investigator for this Carcinoid Syndrome clinical trial currently being conducted, please click here.

Carcinoid Syndrome Announcement

Endo Pharmaceuticals Solutions, Inc. is currently recruiting participants of ages 18 years to 80 years old for a clinical trial. The study is an Open Label Study to evaluate the Pharmacokinetics, Efficacy and Safety of Two Doses of an Octreotide Implant in Patients with Carcinoid Syndrome. The study will evaluate an octreotide implant for a period of 9 months. To be considered for this study you must meet the eligibility criteria:

Inclusion Criteria:
  • histological confirmed tumor,
  • documented evidence of carcinoid syndrome,
  • previous positive octreotide scan, and
  • received stable doses of octreotide injections.

Exclusion Criteria:
  • poorly differentiated or high grade neuroendocrine tumor,
  • significant cardiovascular, hepatic, renal or other diseases.

For more Information Contact:
  • 1-800-462-3636
  • ClinicalTrials.gov identifier: NCT00884715

CLINICAL STUDIES

If you are interested in being an investigator for Endo clinical trials, please click here.

If you are interested in participating in the ACROMEGALY clinical trial, please see below.


ACROMEGALY

If you have Acromegaly, are of ages 18 years to 80 years old and are interested in being considered to participate in a clinical trial currently being conducted, please click here.

If you are a physician interested in being an investigator for this Acromegaly clinical trial currently being conducted, please click here.

Acromegaly Clinical Trial Announcement

Endo Pharmaceuticals Solutions, Inc. is currently recruiting participants of ages 18 years to 80 years old for a clinical trial. The study is an Open Label, Multicenter International Study to Evaluate the Efficacy and Safety of an Octreotide Implant versus Sandostatin LAR Depot in Patients with Acromegaly. The study will evaluate an octreotide implant for a period of 6 months. To be considered for this study you must meet the following eligibility criteria:

Inclusion Criteria:
  • confirmed diagnosis of a growth hormone-secreting tumor,
  • received a stable dose of monthly octreotide depot injections for a minimum of 3 consecutive months immediately prior to screening,
  • previous positive octreotide scan, and
  • must have a normal IGF-1 and GH levels.

Exclusion Criteria:
  • patients with pituitary surgery less than 3 months prior to screening,
  • received pegvisomant, Lanreotide, or dopamine agonist within 3 months of screening, or at any time during the trial, and
  • received radiotherapy for pituitary tumor or any radiotherapy above the neck at any time before screening.

For more Information Contact:
  • 1-800-462-3636
  • ClinicalTrials.gov identifier: NCT00765323

CLINICAL STUDIES

If you are interested in being an investigator for future Endo clinical trials, please click here

If you are interested in participating in PAGOCLONE clinical studies, please see below.


PAGOCLONE

If you are an adult who stutters and are interested in being considered to participate in future clinical trials, please click here.

If you have a child, under the age of 18, who stutters and you would like them to be considered for participation in
future clinical trials, please click here.

If you are a physician interested in being an investigator for future clinical trials, please click here.